Patent Yard Sign in
Canadian application, no grantCanada

Neisseria lactoferrin binding protein

CA 2301332 A1 · Owner: Tommassen, Johannes Petrus Maria · Inventors: Tommassen, Johannes Petrus Maria; Pettersson-Fernholm, Annika Margareta

CIPO record

Overview

Drawings and full text

Its claims, description and drawings are in the Canadian Patents Database.

Open the CIPO record

Abstract From the Canadian patent

LbpB polypeptides and polynucleotides and methods for producing such polypeptides by recombinant techniques are disclosed. Also disclosed are methods for utilizing LbpB polypeptides and polynucleotides in the design of protocols for the treatment of neisserial disease among others, and , diagnostic assays for such conditions.

Read the whole patent

Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.

Why it's free to use

  • Filed August 10, 1998. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended August 10, 2018.
  • A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by August 10, 2020.
  • We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledAugust 10, 1998
GrantedNo grant recorded
Term endedAugust 10, 2018
Patent numberCA 2301332 A1
Classification (IPC)C12N15/31 +2 more

Timeline

Timeline From CIPO dates

1999200120032005200720092011201320152017Application filedAug 10, 1998Term endedAug 10, 2018

Sources & verification

Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.